Carbonell, R.; Moreno, G.; Martín-Loeches, I.; Gomez-Bertomeu, F.; Sarvisé, C.; Gómez, J.; Bodí, M.; Díaz, E.; Papiol, E.; Trefler, S.;
et al. Prognostic Value of Procalcitonin and C-Reactive Protein in 1608 Critically Ill Patients with Severe Influenza Pneumonia. Antibiotics 2021, 10, 350.
https://doi.org/10.3390/antibiotics10040350
AMA Style
Carbonell R, Moreno G, Martín-Loeches I, Gomez-Bertomeu F, Sarvisé C, Gómez J, Bodí M, Díaz E, Papiol E, Trefler S,
et al. Prognostic Value of Procalcitonin and C-Reactive Protein in 1608 Critically Ill Patients with Severe Influenza Pneumonia. Antibiotics. 2021; 10(4):350.
https://doi.org/10.3390/antibiotics10040350
Chicago/Turabian Style
Carbonell, Raquel, Gerard Moreno, Ignacio Martín-Loeches, Frederic Gomez-Bertomeu, Carolina Sarvisé, Josep Gómez, María Bodí, Emili Díaz, Elisabeth Papiol, Sandra Trefler,
and et al. 2021. "Prognostic Value of Procalcitonin and C-Reactive Protein in 1608 Critically Ill Patients with Severe Influenza Pneumonia" Antibiotics 10, no. 4: 350.
https://doi.org/10.3390/antibiotics10040350
APA Style
Carbonell, R., Moreno, G., Martín-Loeches, I., Gomez-Bertomeu, F., Sarvisé, C., Gómez, J., Bodí, M., Díaz, E., Papiol, E., Trefler, S., Nieto, M., Estella, A., Jiménez Herrera, M., Vidal Cortés, P., Guardiola, J. J., Solé-Violán, J., & Rodríguez, A.
(2021). Prognostic Value of Procalcitonin and C-Reactive Protein in 1608 Critically Ill Patients with Severe Influenza Pneumonia. Antibiotics, 10(4), 350.
https://doi.org/10.3390/antibiotics10040350